中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
18期
1275-1277
,共3页
胆管癌%预后%外科手术
膽管癌%預後%外科手術
담관암%예후%외과수술
Cholangiocarcinoma%Neoplasms%Prognosis
目的 探讨影响肝门部胆管癌术后预后的因素.方法 回顾性分析2004年1月-2008年7月收治86例肝门部胆管癌的临床资料,分析影响肝门部胆管癌预后的因素.结果 全组患者的平均生存时间为(13.7±2.3)个月.1年生存率为57.3%,3年生存率为29.7%.切除组(包括根治性切除和姑息性切除)的平均生存时间(19.4±2.2)个月,高于非手术切除组患者的平均生存期(7.2±1.2)个月(P<0.05).无血管切除组患者的平均生存期为(23.4 ±2.1)个月,明显高于单纯门静脉切除组(15.3±1.4)个月及肝动脉切除组(9.3±0.9)个月(P<0.05).Cox回归模型分析显示分期、肿瘤直径和手术方式是影响肝门部胆管癌患者预后的因素.而病理类型、血管切除和年龄并不是影响肝门部胆管癌患者预后的因素.结论 肝门部胆管癌的预后与手术治疗方式、肿瘤分期和肿瘤直径因素密切相关.在治疗过程中应慎重选择手术治疗方式.
目的 探討影響肝門部膽管癌術後預後的因素.方法 迴顧性分析2004年1月-2008年7月收治86例肝門部膽管癌的臨床資料,分析影響肝門部膽管癌預後的因素.結果 全組患者的平均生存時間為(13.7±2.3)箇月.1年生存率為57.3%,3年生存率為29.7%.切除組(包括根治性切除和姑息性切除)的平均生存時間(19.4±2.2)箇月,高于非手術切除組患者的平均生存期(7.2±1.2)箇月(P<0.05).無血管切除組患者的平均生存期為(23.4 ±2.1)箇月,明顯高于單純門靜脈切除組(15.3±1.4)箇月及肝動脈切除組(9.3±0.9)箇月(P<0.05).Cox迴歸模型分析顯示分期、腫瘤直徑和手術方式是影響肝門部膽管癌患者預後的因素.而病理類型、血管切除和年齡併不是影響肝門部膽管癌患者預後的因素.結論 肝門部膽管癌的預後與手術治療方式、腫瘤分期和腫瘤直徑因素密切相關.在治療過程中應慎重選擇手術治療方式.
목적 탐토영향간문부담관암술후예후적인소.방법 회고성분석2004년1월-2008년7월수치86례간문부담관암적림상자료,분석영향간문부담관암예후적인소.결과 전조환자적평균생존시간위(13.7±2.3)개월.1년생존솔위57.3%,3년생존솔위29.7%.절제조(포괄근치성절제화고식성절제)적평균생존시간(19.4±2.2)개월,고우비수술절제조환자적평균생존기(7.2±1.2)개월(P<0.05).무혈관절제조환자적평균생존기위(23.4 ±2.1)개월,명현고우단순문정맥절제조(15.3±1.4)개월급간동맥절제조(9.3±0.9)개월(P<0.05).Cox회귀모형분석현시분기、종류직경화수술방식시영향간문부담관암환자예후적인소.이병리류형、혈관절제화년령병불시영향간문부담관암환자예후적인소.결론 간문부담관암적예후여수술치료방식、종류분기화종류직경인소밀절상관.재치료과정중응신중선택수술치료방식.
Objective To investigate the influencing factors on the prognosis of hilar cholangiocarcinoma.Methods The clinical data were retrospectively analyzed in 86 cases of hilar eholangiocarcinoma admitted into our hospital from Jan.2004 to July.2008.Results Of 86 cases with hilar eholangiocarcinoma,the mean survival time was 13.7 ± 2.3 months,1-year survival 57.3% and 3-year survival 29.7%.The mean survival time in patients with resection operation ( 19.4 ± 2.2 months ) was significantly longer than those with no operation ( 7.2 ± 1.2 months) (P < 0.05 ).The mean survival time in patients with non-vascular resection group ( 23.4 ± 2.1 months ) was significantly longer than those with portal vein resection alone group (15.3 ± 1.4 months) and hepatic artery resection group (9.3 ± 0.9month) (P < 0.05 ).Cox regression analysis showed that staging,tumor diameter and operative were the dependent prognosis factors while pathologic type,vascular resection and age not the dependent prognosis factors.Conclusion The prognosis of hilar cholangiocarcinoma correlates with operative approach,clinical stage and tumor diameter.A surgeon must be cautious to choose the surgical approach for treatment.